Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 11.736.17-0.4011.4510.95

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.73 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202411.73
Mar20236.17
Mar2022-0.40
Mar202111.45
Mar202010.95

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2024 11.73
90.11
Mar2023 6.17
Positive
Mar2022 -0.4
Negative
Mar2021 11.45
4.57
Mar2020 10.95 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹5,919.7 Cr 4.4% 9% -21.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,468.0 Cr 3.4% 2.2% 13.6% Stock Analytics
DIVIS LABORATORIES ₹156,319.0 Cr 5.3% 3.9% 51.8% Stock Analytics
CIPLA ₹122,075.0 Cr 3.3% 1.2% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,125.0 Cr 4% 6.3% 29.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,227.9 Cr 6.1% 2.3% -3.2% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

4.4%

9%

-21.1%

SENSEX

7.5%

7.6%

7%


You may also like the below Video Courses